Via Acquires Downtowner to Expand Category-Leading Public Transit Technology Platform
NEW YORK–(BUSINESS WIRE)–Via, the leading provider of technology to power public transit networks, today announced the acquisition of Downtowner, a transportation... Read more.
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
VICTORIA, British Columbia–(BUSINESS WIRE)–$HYFT #ai–MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining... Read more.
SOJI AI and Airborne Capital Limited Announce AI Partnership
DUBLIN–(BUSINESS WIRE)–SOJI AI (“SOJI”), a specialist AI-driven software solutions company and Airborne Capital Limited (“Airborne Capital”),... Read more.
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
Prestigious recognition underscores the impact of large-scale genomic screening in identifying serious childhood genetic conditions in conjunction with traditional... Read more.
Silence Therapeutics Announces Leadership Changes
LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a global clinical-stage... Read more.
Teletrac Navman Report: 84% of Fleets Cite Driver Exoneration as a Leading Reason for Deploying Safety Technology
NORTHBROOK, Ill.–(BUSINESS WIRE)–New research from Teletrac Navman, a leading connected mobility platform and a Vontier company, has found that 84% of... Read more.
The Marygold Companies’ USCF Investments Subsidiary Launches USCF Oil Plus Bitcoin Strategy Fund
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–The Marygold Companies, Inc. (NYSE American: MGLD), a global holding firm specializing in financial services, today... Read more.
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
SYDNEY–(BUSINESS WIRE)–#Clinical–Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company,... Read more.
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis... Read more.
Medical Device Collaboration and Licensing Deals 2016-2025: Comprehensive Listing of 903 Deals Including Financial Terms – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Medical Device Collaboration and Licensing Deals 2016-2025” has been added to ResearchAndMarkets.com’s... Read more.